Skip to main content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Families with Children

Reports

Displaying 41 - 50 of 171. 10 per page. Page 5.

Advanced Search
Fact Sheet

Factsheet: Estimates of Child Care Eligibility & Receipt for Fiscal Year 2019

This factsheet provides descriptive information on child care eligibility and receipt. Of the 12.5 million children potentially eligible for child care subsidies under federal rules, 16 percent received subsidies. Of the 8.7 million children eligible for child care subsidies under more restrictive state rules, 23 percent received subsidies.
Research Summary

Early Childhood Systems Collective Impact Project: Overview

The Early Childhood Systems Collective Impact Project (ECS Collective Impact Project) will help to re-envision a truly coordinated approach to program implementation designed to advance early childhood and family well-being outcomes across federal programs that support expectant parents, children ages 0 to 8, and their families.
Report

Integrating SUD and OB/GYN Care: Policy Challenges and Opportunities Final Report

This report aims to address the treatment care models for pregnant and postpartum women with SUD by describing opportunities to integrate OB/GYN and SUD care as well as barriers to integrated care delivery.Related Products:
Research Brief

The Role of Health and Human Service Providers in Preventing Fetal Alcohol Spectrum Disorders Research Brief

This brief reviews the role of health and human service providers in preventing Fetal Alcohol Spectrum Disorder.Related Products:
ASPE Issue Brief

Integrating OB/GYN and SUD Care Policy Challenges and Opportunities Issue Brief

This brief highlights specific policy challenges and opportunities for policymakers to expand access to integrated services for pregnant and postpartum women with SUD.Related Products:
Research Brief

State Responses to FASD: Effective Strategies and Ongoing Challenges Research Brief

This brief synthesizes effective state and local level strategies for prevention, identification and intervention of Fetal Alcohol Spectrum Disorder.Related Products:
ASPE Issue Brief

Parents’ Intentions to Vaccinate Children for COVID-19 by Child Age: Sociodemographic Factors and Reasons for Hesitancy

This ASPE issue brief examines hesitancy among parents to vaccinate children ages 5-11 and 12-17 using data from the U.S. Census Bureau's Household Pulse Survey. Overall, a larger percent of parents with children aged 5-11 are hesitant to vaccinate their children (34 percent) than parents of children aged 12-17 (21 percent).
ASPE Issue Brief

Child and Caregiver Outcomes Using Linked Data: Project Overview

The Child and Caregiver Outcomes Using Linked Data project provides technical assistance to states to develop state-specific datasets linking the Medicaid administrative claims of parents with the records of their children from the child welfare system. The data will be combined into a multi-state, de-identified data sets for secondary data analysis.

The Impacts and Implications of COVID-19 on Household Arrangements

This brief identifies emerging literature on the impacts and implications of the COVID-19 pandemic on household arrangements as well as considerations for how to best serve multiple individuals and families under one roof during the pandemic and in the future.Related Products:
ASPE Issue Brief

Parents' Intentions to Vaccinate Children Ages 12-17 for COVID-19: Demographic Factors, Geographic Patterns, and Reasons for Hesitancy

As of September 13, 2021, three vaccines to prevent infection with SARS-CoV-2, the virus that causes COVID-19, are available in the United States. The Pfizer vaccine was granted full approval for use in individuals over the age of 16 by the U.S.